Visceral fat obesity increases serum DPP-4 levels in men with type 2 diabetes mellitus
详细信息 查看全文
- 作者：Sayuri Tanaka
- 关键词：DPP-4 ; dipeptidyl peptidase-4 ; T2DM ; type 2 diabetes mellitus ; MetS ; metabolic syndrome ; GLP-1 ; glucagon-like peptide 1 ; GIP ; gastric inhibitory polypeptide
- 刊名：Diabetes Research and Clinical Practice
- 出版年：2016
- 出版时间：June 2016
- 年：2016
- 卷：116
- 期：Complete
- 页码：1-6
- 全文大小：294 K
文摘
- •
DPP-4 is a therapeutic target of diabetes mellitus and atherosclerosis.
- •
The association between serum DPP-4 levels and visceral fat mass is still unclear.
- •
The association between serum DPP-4 and visceral fat mass was examined.
- •
Multiple regression and logistic analyses adjusted for confounding factors were done.
- •
High serum DPP-4 level is associated with accumulation of visceral fat.